CITRAVESCENT granules sachet (reformulation)

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

sodium bicarbonate, Quantity: 1.32 g; citric acid, Quantity: 1.23 g; tartaric acid, Quantity: 0.4 g; sodium carbonate, Quantity: 0.08 g

Tilgængelig fra:

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

INN (International Name):

citric acid,sodium bicarbonate,sodium carbonate,tartaric acid

Lægemiddelform:

Granules, effervescent

Sammensætning:

Excipient Ingredients: lactose monohydrate; sucrose

Indgivelsesvej:

Oral

Enheder i pakken:

8 sachets, 10 sachets, 25 sachets, 28 sachets, 20 sachets

Recept type:

Not scheduled. Not considered by committee

Terapeutiske indikationer:

Systemic and urinary alkalinisation where indicated in the relief of symptoms associated with urinary tract infections such as cystitis, pyelonephritis, urethritis; and in reducing the formation of uric acid and cystine calculi. Citravescent may increase the effectiveness of sulphonamide antibiotics in the treatment of urinary tract infection. Acid indigestion or heartburn.

Produkt oversigt:

Visual Identification: White granules; Container Type: Sachet; Container Material: Al laminated with LDPE/paper; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Autorisation status:

Licence status A

Autorisation dato:

2013-08-15